Intravenous vitamin C given to patients with lung cancer nearly doubled the shrinking of their tumors after chemo.
“Around 93% of the people receiving the intravenous vitamin C are responding to chemotherapy and radiation, compared to 40% who usually do. The intravenous vitamin C may also show encouraging results in a small sample of people with glioblastoma.”